Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 3Phase NA 1Phase 2/3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 7Glioma 5Central Nervous System Neoplasms 5Brain Neoplasms 3Astrocytoma 3Oligodendroglioma 2Lymphoma 2Gliosarcoma 2Spinal Cord Neoplasms 1Sarcoma 1Recurrence 1Neoplasms 1Leiomyosarcoma 1Hyperthermia 1Ependymoma 1Depression 1

Interventions

Radiosurgery 3Magnetic Resonance Imaging 3Vincristine 2Surveys and Questionnaires 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Carboplatin 2Temozolomide 1Standard of Care 1Restraint, Physical 1Patient Discharge 1Neurofibromin 1 1Gelclair 1Fluorodeoxyglucose F18 1Etoposide 1Elasticity Imaging Techniques 1Cryosurgery 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Spinal Cord Neoplasms × Temozolomide × Clear all
NCT00077207 2018-05-16

Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma

Children's Oncology Group

Phase NA Completed
66 enrolled 13 charts
CNS

Brain Neoplasms, Oligodendroglioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡